@wellnessivinfusionsgmail-com. The compounds discussed were sytrinol and Leucine w/ Nicotinic Acid.
The studies done on leu +NA are pre-clinical models showing that you can decrease the dose of NA by 95% and still get the same therapeutic outcome without the side effects or increased risk of insulin resistance normally seen with higher doses of NA.
Here is that paper https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435603/
Sytrinol human studies paper on dyslipidemia is here https://pubmed.ncbi.nlm.nih.gov/17985810/
Sytrinol has a polymethoxylated flavone called Nobelitin, which is what Dr. Seeeds was referring to regarding cancer research. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277899/
Nobiletin was also shown in pre-clinical models to improve hepatic fatty acid oxidation and improve dysregulated circadian rhythms associated with metabolic dysfunction.
-long-term supplementation with low-dose NOB can protect against HFD-induced inflammation, insulin resistance, dyslipidemia, and nonalcoholic fatty liver disease, without ameliorating adiposity. https://pubmed.ncbi.nlm.nih.gov/28116779/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832569/
Sytrinol is hard to find sometimes and is currently sold out at nuBioAge but it can be compounded.
nuBioAge is also currently compounding Leucine + nicotinic acid + Sytrinol in a capsule.
.